» Articles » PMID: 30988911

Pitfalls in Gd-EOB-DTPA-Enhanced Liver Magnetic Resonance Imaging With an Emphasis on Nontumorous Lesions

Overview
Specialty Gastroenterology
Date 2019 Apr 17
PMID 30988911
Citations 1
Authors
Affiliations
Soon will be listed here.
Citing Articles

Outcomes of different parenchymal-sparing hepatectomies in patients with colorectal liver metastases and prognostic impact of peritumoral imaging features.

Liu L, Xie L, Zhou Y, Li Q, Lei X, Tang H Abdom Radiol (NY). 2023; 48(12):3728-3745.

PMID: 37750923 DOI: 10.1007/s00261-023-04044-3.

References
1.
Kelekis N, Makri E, Vassiou A, Patsiaoura K, Spiridakis M, Dalekos G . Confluent hepatic fibrosis as the presenting imaging sign in nonadvanced alcoholic cirrhosis. Clin Imaging. 2004; 28(2):124-7. DOI: 10.1016/S0899-7071(03)00243-2. View

2.
Kim S, Lee J, Kim W, Han J, Lee J, Choi B . Focal peliosis hepatis as a mimicker of hepatic tumors: radiological-pathological correlation. J Comput Assist Tomogr. 2007; 31(1):79-85. DOI: 10.1097/01.rct.0000232919.22287.20. View

3.
Sun H, Lee J, Shin C, Lee D, Moon S, Kim K . Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging. Invest Radiol. 2010; 45(2):96-103. DOI: 10.1097/RLI.0b013e3181c5faf7. View

4.
Motosugi U, Ichikawa T, Sou H, Sano K, Tominaga L, Muhi A . Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging. Radiology. 2010; 256(1):151-8. DOI: 10.1148/radiol.10091885. View

5.
Yamamoto A, Tamada T, Sone T, Higashi H, Yamashita T, Ito K . Gd-EOB-DTPA-enhanced magnetic resonance imaging findings of nondiffuse fatty change of the liver. J Comput Assist Tomogr. 2010; 34(6):868-73. DOI: 10.1097/RCT.0b013e3181ef1db1. View